Viewing data from:

NIACIN

ANDA

NIACIN | A203899 | LANNETT CO INC

2 strengths0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
AbbVie Inc. et al v. Kremers Urban Pharmaceuticals Inc. 1:2012cv00703 2 patentsANDA 203899niacin extended release	D. Del.	2012-06-01	Terminated 2013-10-02	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.2893

per ea

Lowest NADAC/Unit

$0.1492

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62175032246NIACIN ER 1,000 MG TABLET	$0.2893	EA	Generic	—	2026-06-17
62135049890NIACIN ER 1,000 MG TABLET	$0.2893	EA	Generic	—	2026-06-17
62175032046NIACIN ER 500 MG TABLET	$0.1492	EA	Generic	—	2026-06-17
62135049790NIACIN ER 500 MG TABLET	$0.1492	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$52.37

Highest Price

$69.70

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0267-90NIACIN (EQV-NIASPAN) 500MG TAB,SA	$52.37	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0268-90NIACIN (EQV-NIASPAN) 1000MG TAB,SA	$69.70	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs4 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

AURORIUM LLCNIACIN USP

DMF 82591989

DIVIS LABORATORIES LTDNIACIN USP

DMF 184812005

AARTI DRUGS LTDNIACIN

DMF 200512006

JUBILANT BIOSYS LTDNIACIN USP

DMF 313822017

WOCKHARDT LTDInactiveNIACIN

DMF 76421988

LONZA AGInactiveNIACIN USP SPECIAL

DMF 80411989

LONZA LTDInactiveNIACIN USP GRANULAR SPECIAL

DMF 182932005

ABBVIE INCInactiveNIACIN CORE TABLET INTERMEDIATE

DMF 218762008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 500MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Jun 16, 2017

No patent or exclusivity listings for this strength.

#002 — 1GM

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Jun 16, 2017